Nanomedicine Market by Modality (Treatments and Diagnostics), Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, and Others), and Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, Ophthalmological Diseases, Immunological Diseases, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL1548221
  • 190 Pages
  • August 2017
  • Healthcare

Nanomedicine is a branch of medicine that uses tools and knowledge of nanotechnology for prevention and treatment of different diseases. Nanomedicines are multifunctional drugs with programmable properties that find applications in monitoring, construction, repair, and control of biological systems at the molecular level using nanodevices and nanoparticles. These nanomedicines have the potential to revolutionize the current scenario of detection of disease, its treatment, and diagnosis methods. The global nanomedicine market accounted for $111,912 million in 2016, and is anticipated to reach $261,063 million by 2023, registering a CAGR of 12.6% from 2017 to 2023.

The global nanomedicine market is driven by emerging innovative technologies for drug delivery, advantages of nanomedicine in various healthcare applications, rise in government support and funding, and growth in need for safe and cost-effective therapies. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, increase in out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are anticipated to provide numerous opportunities for the market growth.

The global nanomedicine market is segmented based on modality, application, indication, and region. Based on application, it is classified into drug delivery, diagnostic imaging, vaccines, regenerative medicine, implants, and others. Based on indication, it is categoried into oncological diseases, neurological diseases, urological diseases, infectious diseases, ophthalmological diseases, orthopaedic disorders, immunological diseases, cardiovascular diseases, and others. On the basis of modality, it is bifurcated into treatments and diagnostics.
Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the global market, owing to increase in presence of stronger players focussed on R&D activities and commercialization of nanomedicines in the region. In addition, this region leads in the number of nanotechnology patent applications resulting in higher demand in the market. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the rapid development of healthcare infrastructure and growth in health awareness among the middle-class population.

The key players operating in the global market have focused on expanding their presence in the nanomedicine sector. Moreover, new players moving into healthcare contribute by expanding expertise range, leveraging diversification, and augmenting scale by providing the necessary capital for the nanomedicine development.


  • The study provides an in-depth analysis of the global nanomedicine market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.


By Application

  • Drug Delivery
  • Vaccines
  • Diagnostic Imaging
  • Regenerative Medicine
  • Implants
  • Others

By Modality

  • Diagnostics
  • Treatments

By Indication

  • Oncological Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Orthopedic Disorders
  • Neurological Diseases
  • Urological Diseases
  • Ophthalmological Diseases
  • Immunological Diseases
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


  • Abbott Laboratories
  • CombiMatrix Corporation
  • General electric Company
  • Sigma-Tau Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Mallinckrodt plc.
  • Merck & Company, Inc.
  • Nanosphere, Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.

The other players in the value chain include (profiles not included in the report)

  • Celgene Corporation
  • UCB (Union Chimique Belge) S.A.
  • AMAG Pharmaceuticals
  • Nanospectra Biosciences, Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • Leadiant Biosciences, Inc.
  • Epeius Biotechnologies Corporation
  • Gilead
  • Cytimmune Sciences, Inc.
  • NanoCarrier
  • LTT BioPharma
  • Mebiopharm
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



U.S. NPWT Devices Market - Opportunities and Forecast, 2015 - 2020

Negative Pressure Wound Therapy (NPWT) devices are used to heal wounds by applying sub-atmospheric pressure using sealed dressing connected to vacuum pump. The vacuum source generates negative pressure to remove ...

April 2018| $2850 | Pre Book Price:$2494

Asian Chromatography Solvents Market - Opportunities and Forecasts, 2015 - 2020

Chromatography is a technique used for separation of mixtures for advanced use. Chromatography solvents, such as methanol, chloroform, ethanol, and others are used for separation of mixtures. One component solvent ...

April 2018| $2850 | Pre Book Price:$2494

Intra-Dialytic Hypotension (IDH) Asia-Pacific Market Research Report, 2013 - 2020

Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ≥20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, ...

April 2018| $2850 | Pre Book Price:$2494

Asia Colonoscopy Devices Market - Opportunities and Forecasts, 2014 - 2020

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the ...

April 2018| $2850 | Pre Book Price:$2494

European Dermatology Diagnostic Devices Market- Opportunities and Forecasts, 2014 - 2020

The healthcare sector across Europe is witnessing a dramatic shift and is inclined towards less invasive diagnostic procedures. Dermatology diagnostic equipment aids in both easy as well as painless diagnosis. ...

April 2018| $3390 | Pre Book Price:$2967

Asia Pacific Spine Surgery Devices Market - Opportunities and Forecasts, 2015 - 2020

Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such ...

April 2018| $2850 | Pre Book Price:$2494

2018 © Copyright Big Market Research

View Pricing >>